Palisade Bio (PALI) Soars 5% Ahead of Clinical Trial Results
Palisade extended its winning streak to a fourth straight day on Wednesday, jumping 5.26 percent to close at $2.20 apiece as investors loaded portfolios ahead of the results of its clinical trial for ...

